The Cancer Institute offers annual internal funding opportunities specifically for cancer research projects. UAMS additionally offers a variety of internal funding opportunities that are available, but not restricted to, cancer researchers. External funding opportunities of note to cancer researchers may also be highlighted in this section.

Advancing Toxicokinetics for Efficient and Robust Chemical Evaluation Applications Request for Applications (RFA) Now Open

Funding Opportunity Number: EPA-G2019-STAR-D1

Catalog of Federal Domestic Assistance (CFDA) Number: 66.509

Solicitation Opening Date: July 25, 2019 
Solicitation Closing Date: September 10, 2019 : 11:59:59 pm Eastern Time

The U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR) program, is seeking applications proposing to advance the development of chemical toxicokinetic tools and approaches for broader applicability during chemical evaluations, with an emphasis on their application within new approach methodology (NAM) frameworks. Toxicokinetics describes the absorption, distribution, metabolism, and excretion of chemicals and their metabolites by the body, and as such provides a framework for extrapolating in vivo doses of concern from in vitro-derived concentrations that cause perturbations at the cellular or molecular level. The incorporation of new methods, tools and approaches can simultaneously improve predictivity, reduce uncertainty and build confidence in the successful application of such extrapolations.  Learn more

2020 Medical Research Endowment Awards

The guidelines and due dates for the 2020 Medical Research Endowment Awards granted by the UAMS Foundation Fund Board.  Approximately $115,000 from the endowment income will be available for research projects in 2020.
The application deadline for your submission will be July 19, 2020 at 5:00pm.  Your submission will have reviewed by an internal committee of faculty from the Colleges of Medicine, Nursing, Pharmacy, Public Health, Health Professions and the Graduate School.  Following reviews and recommendations, the UAMS Foundation Fund Board will approve the list of award recipients.

Please review the application guidelines and the NIH biographical sketch format carefully.  Non-conforming applications will be returned without review.  In addition, all applicable approvals and documented verifications (HRAC, biohazard, animal use, etc.) may be obtained after the grant has been approved by the UAMS Foundation Fund Board but must be complete before funds are distributed.

We anticipate completion of the review process by September 30, 2019, in order to initiate the grant year beginning January 1, 2020.

Download the guidelines

Full Proposal Mechanism Non-Pilot Award
Applications due: 5:00 pm, Wednesday, July 10, 2019

ABCRP will fund research proposals with a maximum budget of $250,000. Funding is for one year beginning September 1, 2019 and ending August 31, 2020. Awards will be announced in late August 2019. The number of proposals that will be funded is not predetermined.

Download PDF Application

Pilot Mechanism Award
Applications due: 5:00 pm, Wednesday, July 10, 2019

ABCRP will fund research proposals with a maximum budget of $75,000. Exceptions may be made for extraordinary proposals. Funding is for one year beginning September 1, 2019 and ending August 31, 2020. Awards will be announced in late August 2019. The number of proposals that will be funded is not predetermined.

Download PDF Application

Funding for Pilot Projects Available to UAMS-Affiliated Faculty

The Center for Microbial Pathogenesis and Host Inflammatory Responses is a COBRE funded by the NIGMS whose goal is to facilitate infectious disease research at UAMS and its affiliated campuses. The overall theme is to define interactions between diverse microbial pathogens and their common human host as a necessary prelude to the development of novel diagnostic and therapeutic modalities that can be used to manipulate these interactions in favor of the host.

Award info:

–  Submission deadline – Monday, September 30, 2019 at 5:00 PM

–  Up to $50,000 per year with a start date of May 1, 2020

–  Finalists present applications to the EAC November 12-14, 2019

–  Salary support is allowed for laboratory personnel but not for the PI

–  Carry forward is not allowed, but a second year of support is possible given satisfactory progress

Preference given to:

– Junior investigators who have not previously received R01-level funding

– Senior investigators if the proposal represents a clear expansion of their work in a manner consistent with the underlying theme of the Center

– Projects involving collaboration with Center-funded investigators.

Review criteria will focus on quality of the science, consistency with the underlying theme of the Center, and the potential to enhance the broader research enterprise around this theme.

For questions about suitability, contact the Center Director, Dr. Mark S. Smeltzer, before submitting a proposal (  Administrative questions should be directed to Rhonda Anthony (

Applications must be submitted via e-mail to Rhonda Anthony ( using NIH PHS 398 forms ).  All components typically associated with an R21 submission must be included along with a detailed budget. The PI is responsible for securing institutional clearance and must secure final IRB and/or IACUC approval before an award can be made, and no application will be considered for funding unless approval is finalized on or before May 1, 2020.

Application Format

Budget  1 page
Biosketch (for all key personnel) Up to 5 pages
Specific Aims 1 page
Research Strategy* Up to 6 pages
Vertebrate Animals (if applicable) No limit
Human Subjects Research (if applicable) No limit

*A description on how the work proposed will develop into an R01-level application must be included.

The following citation must be included in all publications, including abstracts, resulting from work done with Center resources: “This work was supported by the Center for Microbial Pathogenesis and Host Inflammatory Reponses through the Center of Biomedical Research Excellence Award P20GM103625 from the National Institute of General Medical Sciences”.  In addition, any subsequent grant awards received as a result of Center support must be reported to the Director immediately upon receipt.

Department of Defense Research Grants

The Department of Defense (DoD) Health Program has a number of research funding opportunities for cancer researchers and the deadlines are fast approaching. Specific areas of focus include prostate cancer, lung cancer, and breast cancer. Awards are available for young investigators, senior researchers, and physician scientists with opportunities in therapeutic clinical trials, basic research, translational research, population science, and health disparities. There is something for everyone, so please apply now! For more information about each funding opportunity, see the DoD Grants page –

Mark Foundation for Cancer Research 2019 Emerging Leader Award

The Mark Foundation Emerging Leader Awards provide grant support to early career investigators conducting high-impact, high-risk cancer research. This award is intended to support highly promising projects for which other sources of funding are not readily available or for a separate innovative endeavor that will allow the applicant to pursue a distinct and novel research direction.

Eligible candidates must have a PhD, MD, or equivalent and be 3-8 years from the start of an independent faculty research appointment as of December 31, 2019.  Projects should be centered on evidence-based laboratory, data, and medical science.  The award is not intended to be the main source of funding for the applicant’s laboratory – applicants should also have 1-2 NIH R01s, NSF CAREERs, or equivalently substantial awards.

Award Terms

  • $250,000 per year for three years totaling $750,000
  • Indirect costs not to exceed $25,000 per year (included in the award total)
  • Letters of Intent due on May 10, 2019
  • Applications due on July 12, 2019
  • Award start date will be January 1, 2020

Applicants should review The Mark Foundation’s 2019 Emerging Leader Award Policies before applying –

For more information, including eligibility, submission process, and key dates –

Pilot Awards to Address Health Challenges of Rural and Underrepresented Populations

The UAMS Office of Vice Chancellor for Research, Shuk-Mei Ho, Ph.D., and UAMS Translational Research Institute (TRI) are pleased to invite applications for a special pilot grant targeting the health challenges of rural and underrepresented populations. The purpose of this pilot grant opportunity is for faculty members to form new teams to generate data necessary to submit competitive grant proposals in response to NIH, other federal agencies, and foundation grant funding opportunities addressing the health challenges of rural and underrepresented populations.

All UAMS faculty are invited to apply.  Priority will be given to projects: 1) that will generate critical data to better position the research team for future funding; 2) that are likely to facilitate new, multi-disciplinary research collaborations, and/or that are likely to ultimately obtain extramural funding. These awards will NOT support projects that are minor offshoots of ongoing research by an already funded investigator.  Likewise, these awards will NOT provide bridge funding to previously funded investigators.

Award Terms

  • Budgets of up to $50,000 will be considered for the one-year awards
  • Letters of Intent are due by noon on April 26, 2019
  • Applications are due by noon on May 24, 2019
  • Award start date will be June 30, 2019

For more information, please view the Request for Applications.

Contact: Nia Indelicato,, or 501-526-0363.

Request for KL2 Career Development Applications

The UAMS Translational Research Institute (TRI) offers a unique mentored career development opportunity for early career UAMS faculty. The KL2 Scholars Program is a 2-year program of intensive mentored training in clinical and/or translational science and an innovative educational curriculum.

**This year, for the first time, the Cancer Institute will be partnering with the TRI KL2 program to offer an additional KL2 award specifically for an investigator conducting breast cancer research**

KL2 Scholars receive:

  • Salary support of up to $95,000/ year for two years (includes fringe)
  • Up to $25,000/year for two year for non-salary support to be used for research, tuition, travel expenses, educational materials or other costs related to the scholars research

In return, the KL2 Scholar must dedicate a minimum of 75% effort to the program. The Scholar’s home department or college must agree to provide salary supplementation to accommodate the 75% KL2 effort if needed.

The Cancer Institute encourages all early career cancer researchers to apply.

If you are interested in

KL2 application information and instructions

Learn more about the KL2 program

Learn more about past KL2 Scholars

National Cancer Institute (NCI) has announced 2019 Cancer Moonshot funding opportunities

Deadline:  Varies

Funding opportunities listed here highlight research initiatives that align with the efforts of the Cancer Moonshot.

American Association for Cancer Research (AACR) announces new funding opportunities

Deadline: Varies


Visit the AACR to search multiple new funding opportunities

Department of Health and Human Services Invites Applications for Modular R01s in Cancer Control and Population Sciences

RFP Released July 24, 2018

Application Deadlines Vary but Include November 7, 2018 and March 6, 2019

This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science. Learn More

College of Medicine Intramural Grant Program

Awards are made only to full-time faculty members (including VA appointments) of the College of Medicine who are at the rank of instructor or above. Fellows, postdocs, and individuals in temporary positions are not eligible. Individuals at the level of instructor require a letter from the department Chairperson confirming that the individual is not in a temporary position and that the department intends to develop the individual as a faculty member. Recipients may hold only one College of Medicine Intramural Grant at a time. Individual programs have additional eligibility requirements that are described below. Eligible faculty members may submit only one application per deadline on which they are Principal Investigator.  Learn More

Broad Area Announcement (BAA) by FDA for Extramural Funding Opportunities

BAA Released February 14, 2018 and will remain “open until further notice”

Rivkin Center for Ovarian Cancer

RFP Released September 5, 2017; Application Deadlines vary.

The Rivkin Center out of Seattle, WA offers multiple streams of funding to support ovarian cancer across the country. Please follow the link for current requests for eligibility, (varies with grant type) applications, guidelines, and forms.

The Rivkin Center has added one-year awards at $75,000 each, Pilot Study Program awards will support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered.

UAMS Vice-chancellor for Research Grant Opportunities

Application Deadlines Vary

Two new campus-wide grant programs are sponsored through the Office of the Vice-Chancellor for Research.

  • The DEAP grant program, which provides funds to help investigators address reviewer comments on scored, but unfunded grant
  • 2.  The Faculty Research Enhancement (FRE) award, which is a new program to provide short-tern support to enhance research capabilities

Read more about these programs at: